Patient info Open main menu

Simple Eye Ointment – Summary of Product Characteristics (SmPC) for healthcare professionals

Last updated: · Text from the MHRA, as of · About this document

Medicine status: No longer supplied Details

The Summary of Product Characteristics (SmPC) is written for healthcare professionals. Patients will find plain advice in the patient information leaflet: how to take, side effects, other medicines, pregnancy and breast-feeding.

Medicine strength:
800 mg/gram + 100 mg/gram + 100 mg/gram
Still supplied:
The same active substances, strength and form in the NHS Dictionary of Medicines and Devices (dm+d). Ask your pharmacist or doctor before changing to another make.
Contains active substances:

Summary of Product Characteristics (SmPC) - Simple eye ointment

1 NAME OF THE MEDICINAL PRODUCT

Simple Eye Ointment

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

Simple Eye Ointment contains:

Yellow Soft Paraffin

Liquid Paraffin

Wool Fat

80%w/w 10%w.w 10%w/w

3 PHARMACEUTICAL FORM

Eye ointment

Smooth, straw coloured (yellow), translucent ointment.

4 CLINICAL PARTICULARS

4.1 Therapeutic indications

Simple Eye Ointment is a bland sterile preparation indicated for the softening of crusts in blepharitis, as a lubricant at night and to protect the ocular surface e.g. in keratitis, corneal conditions or during surgery.

4.2 Posology and method of administration

Apply a ribbon of ointment between the lower eyelid and the eye. As this product contains no medicament it may be used in the morning and night, or as required.

4.3 Contraindications

Hypersensitivity to any of the ingredients.

4.4 Special warnings and precautions for use

Discard tube 28 days after first opening. Contact lenses should not be worn during the treatment period.

To avoid contamination during use do not allow the nozzle tip to come in contact with any surface.

4.5 Interaction with other medicinal products and other forms of interaction

None known.

4.6 Fertility, Pregnancy and lactation

Suitable for use in pregnancy and lactation.

4.7 Effects on ability to drive and use machines

Application of the ointment will cause blurring of vision. Patients should not drive or operate machinery until their vision is clear.

4.8 Undesirable effects

Blurring of vision for 5 to 10 minutes after application.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via Yellow Card Scheme at: www.mhra.gov.uk/yellowcard

4.9 Overdose

Not applicable

5 PHARMACOLOGICAL PROPERTIES

5.1 Pharmacodynamic properties

Pharmacotherapeutic group: Other Ophthalmologicals.

ATC code: S01 X.

A bland medicament free sterile ointment which exerts its effect as an emollient.

5.2 Pharmacokinetic properties

A combination of well recognised pharmaceutical constituents with no reported incompatibilities.

5.3 Preclinical safety data

No additional pre-clinical data of relevance to the prescriber is available.

6 PHARMACEUTICAL PARTICULARS

6.1 List of excipients

Not applicable

6.2 Incompatibilities

Not applicable

6.3 Shelf life

3 years (unopened)

1 month (opened)

6.4 Special precautions for storage

Do not store above 25°C.

6.5 Nature and contents of container

LDPE aluminium laminate tube containing 4g sterile eye ointment.

6.6 Special precautions for disposal and other handling

No special requirements for disposal

Any unused medicinal product or waste material should be disposed of in accordance with local requirements.

7 MARKETING AUTHORISATION HOLDER

Tillomed Laboratories Ltd

220 Butterfield

Great Marlings

Luton, LU2 8DL

United Kingdom

8 MARKETING AUTHORISATION NUMBER(S)

PL 11311/0533

9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE

AUTHORISATION

14/06/2000 / 27/09/2005

10 DATE OF REVISION OF THE TEXT

24/09/2018

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 11311/0533

Last revision stated in the text: 24 September 2018 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Simple eye ointment

Active substances Liquid paraffin, Yellow soft paraffin, Wool fat
Strength 800 mg/gram + 100 mg/gram + 100 mg/gram
Pharmaceutical form Eye ointment
Smooth, straw coloured (yellow), translucent ointment.
How is it taken Ocular
Excipients Not applicable
Is it available? No, all its packs are listed as discontinued (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 3 years (unopened)
1 month (opened)
Storage Do not store above 25°C.
Drug group (ATC) Other Ophthalmologicals
  1. S Sensory organ drugs
    1. S01 Ophthalmologicals
      1. S01X Other ophthalmologicals
Marketing authorisation PL 11311/0533 (first authorised 14 June 2000)
Marketing authorisation holder Tillomed Laboratories Ltd
Codes BNF 11080100

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.